Malaria & Global Health Sites

IVCC

http://www.ivcc.com

IVCC is a product development partnership that aims to eliminate barriers to the development of new insecticides for malaria control and develop information systems and tools capable of ensure the effective use of both new and existing pesticides.

Malaria Consortium

http://www.malariaconsortium.org/

The Malaria Consortium is a nonprofit organization dedicating to controlling malaria. In partnership with communities, governments, health systems and NGOs, the Malaria Consortium works to ensure the delivery of effective services for the prevention and treatment of malaria.

Malaria No More

http://www.malarianomore.org

Malaria No More is a non-profit, non-governmental organization determined to end malaria deaths.  Malaria No More makes high-yielding investments of time and capital to speed progress, unlock resources, mobilize new assets and spur the word toward the achievement of this goal.

Malaria Vaccine Initiative

http://www.malariavaccine.org

Established in 1999 through a grant from the Bill & Melinda Gates Foundation, the PATH Malaria Vaccine Initiative (MVI) is a PATH-led product development partnership that aims to accelerate the development, availability and accessibility of malaria vaccines in developing countries.

Medicines for Malaria Venture

http://www.mmv.org

Established in Switzerland in 1999, Medicines for Malaria Venture  (MMV) is a non-profit public-private partnership dedicated to discovering and developing new, affordable and effective antimalarials and facilitating their delivery in malaria-endemic countries.

Population Services International

http://www.psi.org

Population Services International (PSI) is a non-profit organization that delivers life-saving products, services and behavior change communications in the areas of malaria, child survival, HIV and reproductive health. Currently, PSI, in partnership with the London School of Tropical Medicine and Hygiene, is leading a malaria program called ACTwatch, which strives to provide policymakers with recommendations on how to best increase the availability of artemisinin-based combination therapies  in malaria-endemic regions.